Ni Cheng

2.0k total citations
46 papers, 1.5k citations indexed

About

Ni Cheng is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Ni Cheng has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Immunology and 8 papers in Surgery. Recurrent topics in Ni Cheng's work include Cell Adhesion Molecules Research (7 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers) and S100 Proteins and Annexins (6 papers). Ni Cheng is often cited by papers focused on Cell Adhesion Molecules Research (7 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers) and S100 Proteins and Annexins (6 papers). Ni Cheng collaborates with scholars based in United States, China and Macao. Ni Cheng's co-authors include Richard D. Ye, Rong He, Xiaoping Du, Yurong Liang, Feng Qian, Chen Jia, Jian Zhou, Asrar B. Malik, Chengwu Zhang and Lizhi Xu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The EMBO Journal.

In The Last Decade

Ni Cheng

44 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ni Cheng United States 22 777 472 216 153 145 46 1.5k
Nikhlesh K. Singh United States 24 758 1.0× 384 0.8× 184 0.9× 101 0.7× 120 0.8× 66 1.5k
Yoshimi Miki Japan 22 888 1.1× 325 0.7× 157 0.7× 219 1.4× 117 0.8× 41 1.8k
Bruce Jaffee United States 20 775 1.0× 536 1.1× 179 0.8× 122 0.8× 119 0.8× 53 2.2k
Tino Hochepied Belgium 22 1.2k 1.5× 502 1.1× 122 0.6× 147 1.0× 186 1.3× 55 2.0k
Jinguo Chen United States 21 790 1.0× 407 0.9× 124 0.6× 93 0.6× 161 1.1× 52 1.6k
Taras Afonyushkin Austria 27 1.4k 1.8× 455 1.0× 182 0.8× 136 0.9× 219 1.5× 37 2.1k
Zhonghan Yang China 28 836 1.1× 441 0.9× 231 1.1× 231 1.5× 214 1.5× 70 1.9k
Ruijie Liu Australia 23 909 1.2× 592 1.3× 108 0.5× 130 0.8× 181 1.2× 44 2.0k
Matthew R. Alexander United States 17 1.9k 2.4× 425 0.9× 214 1.0× 110 0.7× 215 1.5× 34 2.8k
Latha P. Ganesan United States 24 712 0.9× 642 1.4× 93 0.4× 111 0.7× 247 1.7× 42 1.7k

Countries citing papers authored by Ni Cheng

Since Specialization
Citations

This map shows the geographic impact of Ni Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ni Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ni Cheng more than expected).

Fields of papers citing papers by Ni Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ni Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ni Cheng. The network helps show where Ni Cheng may publish in the future.

Co-authorship network of co-authors of Ni Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Ni Cheng. A scholar is included among the top collaborators of Ni Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ni Cheng. Ni Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Xianpeng, Changchen Xiao, Jiamin Li, et al.. (2025). FMO2 expression confers cardioprotection in doxorubicin therapy while preserving antitumor activity. Journal of Molecular and Cellular Cardiology. 207. 1–12.
2.
Shen, Bo, Yanyan Bai, Aleksandra Stojanović, et al.. (2023). Integrin β3 directly inhibits the Gα13-p115RhoGEF interaction to regulate G protein signaling and platelet exocytosis. Nature Communications. 14(1). 4966–4966. 5 indexed citations
3.
Hu, Jinshan, Leyi Chen, Ni Cheng, et al.. (2023). New Indole Diketopiperazine Alkaloids from Soft Coral‐Associated Epiphytic Fungus Aspergillus versicolor CGF 9‐1‐2. Chemistry & Biodiversity. 20(6). e202300301–e202300301. 7 indexed citations
4.
Li, Shuai, Qi Hou, Bo Zhang, et al.. (2023). Propofol inhibits colon cancer cell stemness and epithelial-mesenchymal transition by regulating SIRT1, Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways. Discover Oncology. 14(1). 137–137. 6 indexed citations
5.
Cheng, Ni, et al.. (2021). LINC01207 promotes prostate cancer progression by sponging miR‑1182 to upregulate AKT3. Oncology Letters. 23(2). 57–57. 2 indexed citations
6.
Cheng, Ni, et al.. (2021). Targeting Gα13-integrin interaction ameliorates systemic inflammation. Nature Communications. 12(1). 3185–3185. 19 indexed citations
7.
Cheng, Ni, et al.. (2021). Gα13 Mediates Transendothelial Migration of Neutrophils by Promoting Integrin-Dependent Motility without Affecting Directionality. The Journal of Immunology. 207(12). 3038–3049. 3 indexed citations
8.
Xu, Zheng, Ying Liang, Michael Keegan Delaney, et al.. (2021). Shear and Integrin Outside-In Signaling Activate NADPH-Oxidase 2 to Promote Platelet Activation. Arteriosclerosis Thrombosis and Vascular Biology. 41(5). 1638–1653. 18 indexed citations
9.
Pang, Aiming, Ni Cheng, Yujie Cui, et al.. (2020). High-loading Gα 13 -binding EXE peptide nanoparticles prevent thrombosis and protect mice from cardiac ischemia/reperfusion injury. Science Translational Medicine. 12(552). 32 indexed citations
10.
Cheng, Ni, Yurong Liang, Xiaoping Du, & Richard D. Ye. (2018). Serum amyloid A promotes LPS clearance and suppresses LPS ‐induced inflammation and tissue injury. EMBO Reports. 19(10). 104 indexed citations
11.
Chen, Mingjie, et al.. (2014). Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2. Immunobiology. 219(12). 916–923. 49 indexed citations
12.
Hu, Ying, et al.. (2013). [Study on the chemical constituents of Clerodendron philippinum var. simplex].. PubMed. 36(1). 67–9. 1 indexed citations
13.
Cheng, Ni, et al.. (2013). Comparison of the methods to detect fish freshness based on near-infrared technology.. Shipin anquan zhiliang jiance xuebao. 4(2). 427–432. 1 indexed citations
14.
Cheng, Ni, et al.. (2012). Advances in research on miR-181 family members and malignant tumors. Tumori. 32(10). 837–841. 1 indexed citations
15.
Cheng, Ni, et al.. (2012). Third‐trimester intrauterine pregnancy complicated by metastatic choriocarcinoma. International Journal of Gynecology & Obstetrics. 122(1). 84–85. 4 indexed citations
16.
Qian, Feng, Ni Cheng, Emily J. Welch, et al.. (2009). A non‐redundant role for MKP5 in limiting ROS production and preventing LPS‐induced vascular injury. The EMBO Journal. 28(19). 2896–2907. 49 indexed citations
17.
He, Rong, et al.. (2008). Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2. Blood. 113(2). 429–437. 142 indexed citations
18.
Cheng, Ni, et al.. (2008). Cutting Edge: TLR2 Is a Functional Receptor for Acute-Phase Serum Amyloid A. The Journal of Immunology. 181(1). 22–26. 233 indexed citations
19.
20.
Yan, Pangke, Masakatsu Nanamori, Meiling Sun, et al.. (2006). The Immunosuppressant Cyclosporin A Antagonizes Human Formyl Peptide Receptor through Inhibition of Cognate Ligand Binding. The Journal of Immunology. 177(10). 7050–7058. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026